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ABSTRACT
Circadian rhythms ensure physiological processes to be coordinated with daily changes
of the surrounding. Circadian rhythm misalignment has been increasingly recognized
to pose health risk for a wide range of diseases, particularly metabolic disorders. The
liver maintains metabolic homeostasis and express many circadian genes, such as the
genes encoding differentiated embryo chondrocyte-1 (DEC1) and small heterodimer
partner (SHP). DEC1 is established to repress transcription through class B E-box
elements, and SHP belongs to the superfamily of nuclear receptors and has multiple Ebox elements in its promoter. Importantly, DEC1 and SHP are expressed in an inverse
oscillating manner. The present study was performed to test the hypothesis that the SHP
gene is a target gene of DEC1. In cotransfection experiments, we have demonstrated
that DEC1 repressed the SHP promoter and attenuated the transactivation of the classic
circadian

activator

complex

of

Clock/Bmal1.

Site-directed

mutagenesis,

electrophoretic mobility shift assay and chromatin immunoprecipitation established that
the repression was achieved through the E-box in the proximal promoter.
Overexpression of DEC1 led to decreased expression of SHP. In horse serum-shocked
cells (induction of circadian rhythms), the widely used epileptic agent valproate
inversely altered the expression of DEC1 and SHP. Both DEC1 and SHP are involved
in energy balance and valproate is known to induce hepatic steatosis. Our findings
collectively establish that DEC1 constitutes the negative loop of the SHP oscillating
expression and that the DEC1-SHP pathway is intimately involved in energy
homeostasis with profound pathophysiologic significance.

ACKNOWLEDGMENTS
I would first like to thank my thesis advisor and mentor for the previous 4
years, Dr. Bingfang Yan of the College of Pharmacy at the University of Rhode
Island. I have gained tremendous experience under Dr. Yan’s tutelage and appreciate
the time and effort he has invested in helping me reach my goal. The guidance in
maneuvering through my initial projects that did not yield meaningful results, but
more importantly the support during the past 2 years in completing the project to our
expectations, I truly could not have done this alone. I also would like to thank Dr.
Yan’s wife, Dongfang Yan, for the technical assistance on the weekends, helping
troubleshoot any problems I may have incurred in my techniques performing
experiments. Additionally, I would like to thank all the members of Yan Lab for their
continued support and assistance. Thank You Dr. Yi-Tzai Chen, Dr. Karen Ho,
Yuanjun Shen, and Zhen Xu.
I would also like to acknowledge Dr. Ruitang Deng and Dr. Joel Chandlee
from the University of Rhode Island for being a part of committee and for the valuable
comments and suggested changes to my work though out the project.
Finally, I must thank my mother, Hanna Matczynska, for the constant support
and the endless love and comfort provided during my time at the University of Rhode
Island. This would not at all be possible without her. From the long nights spent in the
lab to numerous days on end where I would not come home, she was always there to
help me and push me towards my goals. I have looked up to her and the amazing
accomplishments she has made throughout her life and just hope to one day to be as
successful. I hope to be a source of pride for you, Dziekuje Mamo, Kocham Ciebie! I

iii

would also like to thank my grandmother, Aleksandra Matczynska, for the unending
moral support all the way from Poland. When struggling or trying to work through
problems, I could always call her. I would also like to thank arguably the most
influential person in my life, my grandfather, Marek Matczynski. I hope he is looking
down full of pride and I hope I am caring on his name as he would have liked me to. I
want to thank my siblings, Tomek and Aleksandra Marczak. I have pushed myself to
do the best I can, trying to be a good role model and inspire them to be even greater. I
cannot wait to see what you two are able to achieve in the future.
Thank you to all my friends for the constant support, and for providing me
some relief when the stress of work would get to me. I love you all and thank you
from the bottom of my heart.

Marek Matczynski Marczak

iv

PREFACE
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Biological Chemistry. It will be submitted for publication in the coming months.
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ABSTRACT
Circadian rhythms ensure physiological processes to be coordinated with daily
changes of the surrounding. Circadian rhythm misalignment has been increasingly
recognized to pose health risk for a wide range of diseases, particularly metabolic
disorders. The liver maintains metabolic homeostasis and express many circadian
genes, such as the genes encoding differentiated embryo chondrocyte-1 (DEC1) and
small heterodimer partner (SHP). DEC1 is established to repress transcription through
class B E-box elements, and SHP belongs to the superfamily of nuclear receptors and
has multiple E-box elements in its promoter.

Importantly, DEC1 and SHP are

expressed in an inverse oscillating manner. The present study was performed to test
the hypothesis that the SHP gene is a target gene of DEC1.

In cotransfection

experiments, we have demonstrated that DEC1 repressed the SHP promoter and
attenuated the transactivation of the classic circadian activator complex of
Clock/Bmal1.

Site-directed mutagenesis, electrophoretic mobility shift assay and

chromatin immunoprecipitation established that the repression was achieved through
the E-box in the proximal promoter.

Overexpression of DEC1 led to decreased

expression of SHP. In horse serum-shocked cells (induction of circadian rhythms), the
widely used epileptic agent valproate inversely altered the expression of DEC1 and
SHP. Both DEC1 and SHP are involved in energy balance and valproate is known to
induce hepatic steatosis. Our findings collectively establish that DEC1 constitutes the
negative loop of the SHP oscillating expression and that the DEC1-SHP pathway is
intimately involved in energy homeostasis with profound pathophysiologic significance.
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INTRODUCTION
Circadian rhythms are physiological changes that follow a 24-h cycle [1]. These
changes ensure physiological processes to be coordinated with daily fluctuations of the
environment [1-3]. Circadian rhythm misalignment has been increasingly recognized
to pose health risk for a wide range of diseases including obesity, diabetes,
cardiovascular diseases and stroke [4-7].

Mammals have central and peripheral

circadian clocks [8]. The central clock is located in the suprachiasmatic nucleus (SCN)
of the hypothalamus and is entrained by such environmental cues as the light-dark
cycle [9, 10]. Through the retinohypothalamic tract, the SCN receives photic input
signals and generates rhythms, which subsequently synchronize multiple peripheral
clocks through neural and humoral signaling [9-12]. While each organ has its own
clock, the liver clock is the most studied peripheral clocks, particularly related to food
cues [13-16].

Circadian rhythms are controlled by a group of core clock genes such as Clock
(circadian locomotor output cycles kaput) and Bmal1 (brain and muscle ARNT-like 1)
[8, 17].

Clock and Bmal1 form a heterodimer and transactivate through E-Box

elements the Per (Period-1 and 2) and Cry genes (Cryptochrome-1 and 2). Per and
Cry proteins in turn interact with Clock/Bmal1 and attenuate their own transactivation
[5, 8, 17]. In addition to Clock/Bmal1, we and other investigators have demonstrated
that DEC transcription factors, differentiated embryo chondrocyte-1 and 2, are strong
E-box binding proteins [18-20]. However, binding to E-box by DEC transcription factors
leads to efficacious repression of the target genes including Per1. DEC1 and DEC2
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are both central and peripheral oscillators [15].

In particular, DEC1 has been

recognized to play fundamental roles in orchestrating metabolism and resetting the liver
clock. Indeed, DEC1 is one of the most sensitive genes in responding to food cues. A
30 min feeding significantly induces the hepatic expression of DEC1 [15].

In addition to DEC1, there are several other well-characterized hepatic circadian genes
such as the gene encoding small heterodimer partner gene (SHP) [5, 21, 22]. SHP
has been established as a major regulator of diverse metabolic pathways, particularly
in bile acid synthesis, lipid metabolism, glucose homeostasis and liver fibrogenesis
[23].

Structurally, SHP belongs to the superfamily of nuclear receptors [23, 24].

However, it lacks the DNA binding domain, thus is referred to as an atypical nuclear
receptor. SHP has been shown to interact with nuclear receptors and/or compete for
co-factors (e.g., co-activators or co-repressor), delivering potent regulatory activities at
the transcriptional level [23]. On the other hand, many nuclear receptors have been
shown to support the induction of SHP in response to endobiotics such as bile acids.
In addition to nuclear receptors, the circadian complex of Clock/Bmal1 is a potent
transactivator of the SHP gene [23]. The transactivation is achieved through the
element CACGTG, a special type of E-box recognized by DEC transcription factors
[23]. In mice, the expression of DEC1 and SHP is inversely oscillating [25, 26].

The present study was performed to test the hypothesis that the SHP gene is a target
of DEC1. Cotransfection experiments showed that DEC1 efficaciously repressed the
SHP promoter reporter and attenuated the transactivation of SHP by the Clock/Bmal1
complex. A set of molecular experiments including chromatin immunoprecipitation
established that the repression was achieved through the E-box in the proximal
promoter. Overexpression of DEC1 led to decreased expression of SHP, and valproate
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inversely altered the oscillating expression of DEC1 and SHP.

These findings

collectively establish that DEC1 constitutes the negative loop of the SHP oscillating
expression and that the DEC1-SHP pathway is involved in energy homeostasis with
profound pathophysiologic significance.

MATERIALS AND METHODS
Plasmid
Expression constructs of Bmal1 and Clock were gifts of Dr. Marina P Antoch of the
Cleveland Clinic [27]. The Per1 promoter reporter (Per1-luc) was a gift of Dr. Joseph
S. Takahashi of Northwestern University [28]. The SHP-2.2 Luc reporter was a gift of
Dr. Hueng-Sik Choi of Keimyung University [29]. The 5’ deletion mutants of the SHP
reporter were prepared by inserting a Nhe I-Hind III fragment into the pGL3 basic
vector. These fragments were generated by PCR with primers as described in Table
I. The SHP mutant reporter with a disrupted E-box (E1) was prepared with the same
approach but the mutations were introduced in the forward primer (Table I). The DEC1
expression construct and its mutants (deletion or substitution) were described
elsewhere [18, 30]. All constructs were subjected to sequencing analysis.

Reporter activity and cotransfection
Cotransfection was performed, essentially as described previously [31, 32]. Cells
(293T) were plated in 24-well plates in DMEM media supplemented with 10% fetal
bovine serum at a density of 1.6 x 105 cells per well. Transfection was conducted by
lipofection with Lipofectamine and Plus Reagents (Thermo Fisher Scientific, Waltham,
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MA).

Generally, the transfection mixtures contained DEC1 (0-100 ng) or a

corresponding mutant construct (100 ng), a reporter plasmid (50 ng) and the pRL-null
Renilla plasmid (5 ng) unless otherwise specified. Vector plasmid was used to equalize
the amount of plasmid DNA for each transfection. The transfected cells were cultured
for additional 24 h, washed with PBS and resuspended in passive lysis buffer
(Promega, Madison, WI).

The lysed cells were subjected to 2 cycles of

freezing/thawing. The reporter enzyme activities were assayed with a Dual-Luciferase
Reporter Assay System (Promega). This system contained two substrates, which were
used to determine the activity of two luciferases sequentially. The firefly luciferase
activity, which represented the reporter gene activity, was initiated by mixing an aliquot
of lysates (20 µl) with Luciferase Assay Reagent II. Then the firefly luminescence was
quenched and the Renilla luminescence was simultaneously activated by adding Stop
& Glo Reagent to the sample wells. The firefly luminescence signal was normalized
based on the Renilla luminescence signal.

Electrophoretic mobility shift assay (EMSA)
DEC1 stably transfected cells with a tetracycline-inducible construct [33] were cultured
in the presence or absence of tetracycline (0.1 µg/mL) for 24. Cells were harvested
and nuclear extracts were prepared with a nuclear extraction kit (Active Motif, Carlsbad,
CA). The EMSA experiment was performed with Lightshift Chemiluminescent EMSA
Kit (Thermo Fisher Scientific, Waltham, MA) as described previously [34]. The sense
strand for SHP-187/162 (E1) was synthesized as labeled or non-labeled form (for
competition). Nuclear protein (5 μg) was mixed with binding buffer and then incubated
with a double-stranded biotinylated probe (0.1 pmol) on ice for 20 min. In competition
assays, nuclear extracts were first incubated with an unlabeled probe at a 50x excess
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for 30 min before addition of the labeled probe. For antibody-disruption assay, the
nuclear extracts were first incubated with anti-DEC1 antibody on ice for 20 min and
then with the labeled probe.

As a positive control, the EMSA experiment was

performed with a DEC2 E-box containing probe [18]. The protein-DNA complexes were
resolved by non-denaturing polyacrylamide gel electrophoresis (6%) and transferred
onto a Biodyne® nylon membrane.

The biotinylated probe was detected with

Chemiluminescent Nucleic Acid Detection Module Kit (Thermo Fisher Scientific,
Waltham, MA). The chemiluminescent signal was captured by myECL Imager (Thermo
Fisher Scientific, Waltham, MA).

Chromatin immunoprecipitation (ChIP)
ChIP experiment was performed with Active Motif ChIP-IT Express kit, essentially
described previously [31, 34]. HepG2 Cells were transfected with DEC1 (Flagtagged) by TransfeX (ATCC, Manassas, VA) for 24 h, washed and underwent
cross-linking for 15 min by 1.0% formaldehyde at room temperature, and the
cross-linking was terminated with glycine (final concentration of 125 mM). The
soluble

chromatins

were

prepared

as

described

previously

[31,

34].

Alternatively, DEC1 stably transfected cells were cultured in the presence of
tetracycline (0.1 µg/ml) for 24 h and then processed as described for HepG2 cells.
For ChIP experiment, chromatins were pre-cleared for 2 h at 4°C with protein G
beads pre-treated with herring sperm DNA (0.2 mg/ml) and BSA (0.5 mg/ml). A
fraction of the pre-cleared chromatins was stored at -80°C for later use as an
input.

The pre-cleared chromatins were incubated with anti-Flag antibody

(HepG2) or anti-DEC1 (stably transfected cells) for overnight at 4°C.

As a

negative control, incubation was performed with pre-immune IgG. The antibodybound chromatins and DNA input as well as IgG control chromatins were
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analyzed by PCR for the presence of the genomic fragments containing the Ebox of interest, other E-boxes (not repressed by DEC1) with primers shown in
Table I. The PCR was performed with Platinum Taq DNA polymerase for a total
of 32 cycles at 94°°C for 30 s, 58°°C for 30 s and 68°°C for 60 s. A 3-min initial
denaturation was performed.

Suppressed expression of SHP by DEC1
HepG2 cells were seeded in 8-well chamber slides (2x104 cells/ well and cultured for
24 h. Cells were then transfected with Flag-DEC1 (500 ng) or the vector by TransfeX
reagent.

The transfected cells were cultured for another 24 h and subsequently

washed with ice cold PBS and then fixed with 4% Paraformaldehyde for 10 min at pH
7.4. Cells were washed 3 times with PBS and permeabilization solution (0.1% Triton
X-100) was added for 10 min. Chamber slides were incubated with 1% BSA (2mg/mL)
for 1 h to block nonspecific binding. The slides were incubated overnight with anti-SHP
antibody (H-160, Santa Cruz Biotechnology, Dallas, TX) or anti-Flag antibody (M2,
Sigma-Aldrich, St. Louis, MO) at a dilution of 1:200. The anti-SHP antibody was located
by Alexa Fluor® 488 conjugated goat anti-rabbit IgG (green), whereas the anti-Flag
antibody with Alexa Fluor® 555 conjugated goat anti-mouse IgG (red). Both secondary
antibodies were purchased from Life Technologies (Carlsbad, CA). The slides were
then mounted with ProLong Gold Antifade Mountant (Thermo Fisher). The mounting
media contained 4',6-diamidino-2-phenylindole (DAPI) for staining nuclei (Blue). Cells
were then imaged using confocal microscope.

To provide more quantitative

information, same experiments were performed in 6-well plates and the expression of
SHP and DEC1 was determined by Western blotting.
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Regulated expression of DEC1 and SHP by valproate in serum-shocked circadian
induction
HepG2 cells were seeded in 6- or 24-well plates at a density of 6x105 or 1.5x105
cells/well in low glucose DMEM with 10% delipided FBS. When the confluency reached
75%, cells were shocked with media containing 50% horse serum for 2 h. Thereafter,
the shocked cells were cultured in normal media or the same media containing
valproate at 2 mM. Cells were harvested at 6 h interval. The expression of DEC1 and
SHP was determined by RT-qPCR with Taqman probes.

The TaqMan assay

identification numbers were: DEC1: Hs00186419_m1; SHP: Hs00222677_m1;
GAPDH, 4352934E; and RNA polymerase II, Hs00172187_m1.

Other analyses
The anti-DEC1 antibody against a peptide derived from the C-terminus was described
elsewhere [33]. Protein concentration was determined with BCA assay (Pierce) with
bovine serum albumin as the standard. Data are presented as mean ± SD of at least
four separate experiments, except where results of blots are shown in which case a
representative experiment is depicted in the figures. Statistical significance between 2
means was made according to 1-way ANOVA followed by a DUNCAN’s multiple
comparison test (P < 0.05).

RESULTS
Repression of the SHP promoter by DEC1
DEC1 and SHP are established to play critical roles in a wide range of biological
activities including metabolic homeostasis [23, 35, 36]. Both DEC1 and SHP are
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circadian genes and their expression is inversely rhythmed [25, 26]. We have shown
that DEC1 is a sequence-specific transcription factor that acts on Sp1 site as well as a
specific type of E-box: CACAGT [30, 37]. The SHP promoter and its immediate
upstream sequence contain multiple E-boxes including a CACATG. We therefore
hypothesized that DEC1 transcriptionally regulates the expression of SHP. To test this
hypothesis, we first examined whether DEC1 represses the SHP promoter.
Specifically, cotransfection experiments were performed with an SHP promoter
luciferase reporter in in 293T cells. For comparison, a Per1 reporter was included. We
and other investigators have demonstrated that Per 1 is a circadian gene and
negatively regulated by DEC1 [18, 30].

As shown in Fig. 1, DEC1 repressed both SHP and Per1 reporters and the repression
occurred in a dose-dependent manner. The repression was robust by as much as 90%.
Nevertheless, the SHP reporter was repressed to a greater extent than the Per1
reporter by 10-15% depending on the amount of DEC1 construct used for the
transfection (Fig. 1A).

We next tested whether DEC1 attenuates Clock/Bmal1-

transactivation of the SHP and Per1 promoters, as the Clock/Bmal1 heterodimer has
been shown to regulate both DEC1 and SHP in a circadian manner [23, 30]. Once
again, cotransfection was performed. As shown in Fig. 1B, Clock/Bmal1 strongly
transactivated both the SHP and Per1 reporters with the Per1 reporter being
transactivated to a greater extent (7 versus 12 fold) (Fig. 1B).

However, the

transactivation of the SHP reporter was attenuated to a much greater extent than that
of the Per1 reporter by DEC1.

For example, DEC1 at 10 ng attenuated the

Clock/Bmal1 transactivation of the SHP reporter by 97%. In contrast, the Clock/Bmal1
transactivation of the Per1 reporter was attenuated by 55% only with the same amount

11

of DEC1. We next tested whether the repression of the SHP promoter requires DNA
binding. As shown in Fig. 1C, no repression was detected with all constructs except
DEC1 (wild-type) and DEC1P56A. We have previously shown that substitution of the
residue proline-56 with an alanine remained the ability for DEC1 to bind to E-box and
deliver repressive activity [18, 30]. In contrast, substitution of the residue arginine-58
with a proline no longer bound to E-box element. These results conclude that DEC1 is
a transcriptional repressor of SHP.

Repression of the SHP promoter by DEC1 through the E-box in the proximal
promoter
The proximal promoter of SHP is an E-box rich region and has as many as 7 E-box
elements [29]. However, these elements differ slightly with 2 of them being CACCTG,
and 1 of the following: CACTTG, CATCTG, CAGCTG, CAGGTG and CACGTG. To
specify whether one or more of these elements support DEC1 repression, deletion and
site-directed mutants of the SHP reporter were prepared and tested for the
responsiveness to DEC1. Once again, DEC1 stably transfected cells were cultured in
the presence or absence of tetracycline and then transfected with a reporter. As shown
in Fig. 2A, all deletion SHP reporters were repressed except SHP-116Luc, suggesting
that the E-box (E1: CACGTG) in the SHP-191Luc reporter supported the repression.
To specify the role of this E-box in DEC1 repression, reporter SHP-191Luc was
subjected to site-directed mutagenesis to selectively disrupt the E-box (CACGTG to
AACGGG). As shown in Fig. 2A, disruption of this E-box completely attenuated DEC1mediated repression of the SHP promoter.
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We next tested whether this E-box interacted directly with DEC1. The DEC1-stable
line was cultured in the presence or absence of tetracycline, and nuclear extracts were
prepared. Double-stranded oligonucleotides harboring this E-box were synthesized
and biotinylated. The labeled probe was incubated with the nuclear extracts and
analyzed by EMSA. As shown in Fig. 2B, incubation with the extracts from the cells
cultured in the presence of tetracycline yielded a shifted band. This band was not
detected when incubation was performed with the extracts from the cell cultured without
tetracycline (lane 11). The shifted band was competed completely by 50× unbiotinylated oligonucleotide (lane 5).

A mutant of this oligonucleotide or

oligonucleotides corresponding to other E-box elements showed no competitive activity
(Fig. 2B, lanes 6-10). In addition, the shifted band disappeared by anti-DEC1 antibody
(disrupted binding).

As expected, a shifted band was detected with biotinylated

oligonucleotide harboring an E-box derived from the DEC2 promoter [18]. In contrast
to the disrupted binding with the SHP E-box (E1), the anti-DEC1 antibody caused the
formation of a supershifted band (Right of Fig. 2B).

To determine whether DEC1 occupies the SHP promoter region that harbors this Ebox (i.e., E1), ChIP experiment was performed. To gain specificity, primers were
designed to amplify three fragments: the binding E-box (BE) fragment (E1 E-box); the
other E-box (OE) fragment (other E-boxes but not binding) and the non E-box (NE)
fragment (no E-box).

As shown in Fig. 2C, chipped DNA showed the abundant

presence of the BE-box fragment (labeled as lane 1) but not the other fragments. As
expected, input DNA produced amplification of all three fragments (Right of Fig. 2C).
It should be noted that pre-immune IgG was used as a control but did not enrich any
fragments. The ChIP experiment was performed with HepG2 cells transfected with
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DEC1 (Flag-tagged) and DEC1 stably transfected cells. Same observation was made
with both cells.
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Effect of DEC1 on the expression of SHP
The reporter assay, EMSA and ChIP experiments established that DEC1 is a
transcriptional repressor of SHP. Next we tested whether DEC1 suppressed the
expression of endogenous SHP.

To test this possibility, HepG2 cells were

transfected with DEC1 (Flag-tagged) or the corresponding vector, and the
expression of SHP was determined. Both Western blotting and immunocytochemistry were used to determine the changes of SHP expression. As expected,
transfection of DEC1 increased immunodetection of DEC1.

Importantly,

transfection of DEC1 decreased the expression of SHP (Right of Fig. 3A). The
suppressed

expression

of

SHP

by

DEC1

was

confirmed

by

immunocytochemistry (Fig. 3A). Overall, transfection of DEC1 led to abundant
Texas-Red staining (DEC1) accompanied by decreased FITC staining (SHP).
Based on the overlay with DAPI staining (blue), both DEC1 and SHP are primarily
present in the nuclei. It should be noted that the transfection was performed with
TransfeX reagent, which delivered high transfection efficiency.

To complement the transfection study, we next tested whether SHP and DEC1
are inversely regulated for their oscillating expression by valproate, a widely
used antiepileptic that was established to down-regulate SHP [38]. Importantly,
valproate is a steatotic agent and both DEC1 and SHP are metabolic regulators.
To mimic circadian rhythm, HepG2 cells were shocked by horse-serum and then
treated with valproate. Cells were collected starting at 6 h after serum-shock and
then at a 6 h interval. Total RNA was isolated and analyzed for the expression of
SHP and DEC1. Both genes were expressed in a circadian manner and the
patterns of the expression were inversed between these two genes (Fig. 3B).
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DISCUSSION
Normal circadian rhythms ensure physiological processes to be coordinated with daily
changes of the environment [1-3].

Circadian rhythm misalignment has been

increasingly recognized to pose health risk for a wide range of diseases [4-7]. The
DEC1 and SHP genes are members of the liver clock and have been shown to play
critical roles in metabolic homeostasis [5, 23, 35, 36]. In this study, we have shown
that the SHP gene is a target of DEC1.

DEC1 efficaciously repressed the SHP

promoter reporter and attenuated the transactivation of SHP by the Clock/Bmal1
complex. Site-directed mutagenesis, EMSA and ChIP identified the E-box element in
the SHP proximal promoter that supported the repression. Overexpression of DEC1
led to decreased expression of SHP. In horse serum-shocked cells (induction of
circadian rhythms), the steatotic drug valproate inversely altered the oscillating
expression of DEC1 and SHP.

These findings establish that DEC1 constitutes the negative loop of the SHP oscillating
expression. It has been reported that the SHP gene is a target of the heterodimer
Clock/Bmal1, a circadian activator complex. The Clock/Bmal1 and Per/Cry pairs are

16

well-established pairs that generate clock outputs by the transcriptional/translational
feedback loop [5]. The Clock/Bmal1 dimer transactivates the Per and Cry genes
through E-box elements, and the Per/Cry interacts with Clock/Bmal1 and attenuates
the Clock/Bmal1 transactivation of Per/Cry. In this study, we have shown that DEC1
repressed the SHP promoter through the same E-box transactivated by the
Clock/Bmal1 dimer, suggesting that DEC1 and Clock/Bmal1 form the transcriptional
feedback loop for the oscillating expression of SHP (Figs. 1A and B). Consistent with
the notion, the expression of DEC1 and SHP is inversely oscillating [25, 26].

It remains to be determined whether the Per/Cry proteins negatively regulate the
expression of SHP. Nonetheless, it is likely that DEC1 exerts a dominant repression,
particularly on the oscillating expression of SHP. In this study, we have shown that
DEC1 repressed both the SHP promoter and the Per1 promoter with the SHP promoter
being repressed to a greater extent (Fig. 1A). Importantly, DEC1 at 10 ng attenuated
the Clock/Bmal1 transactivation of the SHP promoter by as much as 97% but only 55%
on the transactivation of the Per1 promoter (Fig. 1B). In both cases, DEC1 exerted
repressive activity by binding to E-box CACGTG. The SHP E-box is flanked by GTGC
(5’) and GGGT (3’), respectively, whereas the Per1 by TAGC and ACAG, respectively.
It remains to be determined whether the differences in flanking sequences contribute
to the differences in response to DEC1 repression. An early study demonstrated that
the flanking sequences were important for interacting affinity with stra13, the mouse
counterpart of DEC1 [26]. In this study, we have also shown that the antibody against
DEC1 disrupted the shifted band with the SHP E-box (Fig. 2B). In contrast, we have
shown that the same antibody caused a supershift of the DEC2 E-box and the Per1 Ebox [19, 30].
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The DEC1-SHP pathway likely plays critical roles in the synthesis of bile acids,
particularly the circadian production of these endobiotics. While there are several
pathways that have been shown to regulate the synthesis of bile acids, the pathway
mediated by SHP and FXR (farnesoid X receptor) has been extensively studied for the
bile acid–activated regulatory cascade [5, 23]. This cascade is commonly referred as
the bile acid negative feedback inhibition on the expression of the cytochrome P450
enzyme cholesterol 7α-hydroxylase (CYP7A1). CYP7A1 is the first and rate-limited
enzyme in bile acid synthesis. Increased production of bile acids activates FXR,
leading to the induction of SHP. Induction of SHP inactivates LRH-1 (liver receptor
homolog-1) and HNF4α (hepatocyte nuclear factor 4α). In this study, we have shown
that DEC1 downregulated SHP, thus counteracting the feedback inhibition.
Interestingly, the transcription factor DEC2 (functionally related to DEC1) reportedly
repressed the expression of rat CYP7A1 through an E-box: CACATG [39]. This E-box
is conserved in human and mouse based on a BLAST search. It remains whether
DEC1 binds to this E-box and causes repression. Nevertheless, we have reported that
DEC1 negatively regulated the expression of DEC2. It is likely that DEC1 de-represses
CYP7A1 by downregulating SHP and DEC2.

The DEC1-SHP pathway likely serves as an important mechanism for lipid metabolism.
Although there are exceptions, SHP is generally considered to be lipogenic whereas
DEC1 is anti-lipogenic. SHP reportedly augmented the transactivation by PPARγ
(peroxisome proliferator-activated receptor-γ), leading to marked lipid accumulation in
the liver [7]. Likewise, transgenic expression of SHP induced liver steatosis [41].
Consistent with these observations, SHP null mice were protected against diet-induced
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obesity. DEC1, on the other hand, has been shown to repress lipogenic genes such
as fatty acid synthase and inhibit adipogenesis [42, 43]. Overexpression of DEC1 by
viral transduction alleviated fatty liver phenotypes accompanied by suppressed
expression of the lipogenic gene Srebp-1c (sterol regulatory element-binding protein 1c) [35].

Interestingly, SHP null mice supported higher induction of Srebp-1c in

response to cholic acid treatment, suggesting that SHP is a repressor of Srebp-1c [44].
It is not clear whether the observed repression has a broad implication.

The DEC1-SHP pathway may have profound significance in carbohydrate
homeostasis. Patients with type 2 diabetes had higher frequency of loss-of-function
SHP mutants than those without type 2 diabetes (61.5 versus 28.1%) [45]. In addition,
SHP mutation carriers had significantly higher fasting plasma insulin levels than noncarriers [45]. In mice, knockout of SHP developed hepatic insulin resistance [46], and
the antidiabetic metformin ameliorated cytokine-induced hepatic insulin resistance by
inducing SHP [47]. These observations suggest that SHP positively regulates glucose
homeostasis. In contrast, high glucose and high insulin significantly induced DEC1 [48,
49].

The induction of DEC1 was inhibited by LY294002, a strong inhibitor of

phosphoinositide 3-kinases. Importantly, DEC1 protein and the activity of AMPK (5’
AMP-activated protein kinase) showed an inverse circadian rhythm, and knockdown of
DEC1 expression increased AMPK activity [50]. AMPK is known to regulate glucose
homeostasis and prevent insulin resistance [51].

In summary, SHP belongs to the superfamily of nuclear receptors and has been
established to exert a wide range of biological activities, particularly related to metabolic
homeostasis.

Many nuclear receptors and other transcription factors reportedly

19

support the induction of SHP. On the other hand, the SHP gene is transactivated by
the circadian complex of Clock/Bmal1. However, the negative loop of SHP oscillating
expression remains unknown. In this study, we report that DEC1 repressed the SHP
promoter and the repression was achieved through the E-box element in the proximal
promoter region.

We have also demonstrated that transfection of DEC1 led to

decreased expression of SHP. In horse serum-shocked cells, the epileptic agent
valproate (a steatotic drug) inversely altered the expression of DEC1 and SHP. Our
findings collectively establish that DEC1 constitutes the negative loop of the SHP
oscillating expression.

Emerging evidence suggests that alterations on circadian

systems are important risk factors for disease initiation and progression, and the
expression of DEC1 and SHP is rapidly altered by many endobiotics and xenobiotics.
Therefore, de-regulated expression of DEC1 and SHP genes likely alters normal
circadian rhythms and contributes significantly to the pathogenesis of many diseases,
particularly metabolic disorders.
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Table I. Sequences of oligonucleotides
Oligonucleotide

Sequence

Native promoter reporters [numbered according to Kim et al., J. Biol. Chem. (2004),
279:28122-31]
SHP-572 NheI
5’-TCCTAGACTGGACAGTGGG-3’
SHP-240 NheI
5’-GTGAGCGGCAGGTGGCCCT-3’
SHP-190 NheI
5’-GTGATATCAGTGCCACGT-3’
SHP-117 NheI
5’-TGTCTGTGTGTTTTTTTCA-3’
SHP-190m NheI
5’GTGATATCAGTGCAACGGGGGGTTCCCAATGCC-3’
SHP+30 HindIII
5’-GGTTAGGGATCTGCTCTC-3’
EMSA
SHP-187/162 (E1)
SHP-242/217 (E2)
SHP-280/255 (E4/5)
SHP-332/307 (E6)
SHP-347/322 (E7)
SHP-187/162m (E1)
DEC2 E-box

5’-ATATCAGTGCCACGTGGGGTTCCCAA-3’
5’-GAGTGAGCGGCAGGTGGCCCTGTGCC-3’
5’- CTTGTTTATCCACTTGAGTCATCTGA-3’
5’- GCTGATTGTGCACCTGGGGCCTTGGT-3’
5’- CCAATGGGGACACCTGCTGATTGTGC-3’
5’- ATATCAGTGCAACGGGGGGTTCCCAA-3’
5’-TACGTTCCGCACGTGAGCTGGGTG-3’

ChIP
E1 element sense
E1 element antisense
Other E-box element sense
Other E-box element antisense
Non-element sense
Non-element antisense

5’-GGCCCTGTGCCCTGCACCGGC-3’
5’-CTCATGGTTAGGGATCTGCTC-3’
5’-CCTAGTCTTTTGTGCACACAA-3’
5’-TCACCTCAGTCAATGAAGTGG-3’
5’-CAGAAATTCTTGTCACTGTTT-3’
5’-CACACCTCTTTCATTTGATTA-3’
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Fig. 1. Regulation of SHP-luc and mPer1-luc by Clock/Bmal1, DEC1 or in
combination (A) Repression of SHP-Luc and Per1-Luc by DEC1 Cells (293T) were
cultured in 24-well plates at ~80% confluence and transfected with a reporter construct
(50 ng), the pRL-null Renilla (5 ng) and DEC1 (0-100 ng). Vector plasmid was used to
equalize the amount of plasmid DNA for each transfection. The transfected cells were
cultured for 24 h, collected with PBS and resuspended in passive lysis buffer. The
reporter enzyme activities were assayed with a Dual-Luciferase Reporter Assay
System.

The firefly luminescence signal was normalized based on the Renilla

luminescence signal. The signal in the absence of DEC1 was recoded as 100%.
Statistical significance (p<0.05) is denoted by a different letter of a, b and c or x, y and
z. (B) Attenuated Clock/Bmal1 activation by DEC1 Cells were transfected with a
reporter construct (50 ng), the pRL-null Renilla (5 ng), Clock/Bmal1 (100 ng each
labeled as C or B) and DEC1 (0-100 ng labeled as D) and the pRL-null Renilla (5 ng).
Vector plasmid (V) was used to equalize the amount of plasmid DNA for each
transfection. The reporter enzyme activities were assayed with a Dual-Luciferase
Reporter Assay System and normalized based on the Renilla luminescence signal.
The signal was expressed relatively to that in the absence of DEC1.

Statistical

significance (p<0.05) is denoted by a different letter of a, b and c or x, y and z. (C)
Essentiality of DNA binding domain for DEC1 to repress SHP-Luc Cells (293T) were
cultured in 24-well plates and transfected with DEC1 or a DEC1 mutant (100 ng), SHPLuc (50 ng) and the pRL-null Renilla (5 ng). Vector plasmid was used to equalize the
amount of plasmid DNA for each transfection. After a 24 h-incubation, cells were
collected and analyzed for luciferase activities. Similarly, firefly luminescence signal
was normalized based on the Renilla luminescence signal.
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Fig. 2. Identification and characterization of the E-box element in DEC1 binding
(A) Identification of the E-box element in DEC1 binding DEC1 stably transfected cells
were cultured in the presence or absence of tetracycline to modulate the expression of
DEC1 (tetracycline inducible) for 24 h. The cells were then transfected with a reporter
construct (50 ng), the pRL-null Renilla (5 ng) and DEC1 (0-100 ng). The reporter
constructs contained the 5’ sequence of the SHP promoter at different length or a
sequence with a disrupted E-box element.

The transfected cells were cultured,

collected and analyzed for luciferase activity as described above. Once again, the
firefly luminescence signal was normalized based on the Renilla luminescence signal.
The signal in the absence of DEC1 was recoded as 100% for each reporter. (B) EMSA
analysis DEC1-stably transfected cells were cultured in the presence of absence of
tetracycline (0.1 μg/ml) for 24 h, and the nuclear extracts were isolated. For EMSA,
nuclear extracts (5 μg) were incubated with a biotinylated 187/162 (E1) probe for 20
min. In the competition assay, nuclear extracts were pre-incubated with the unlabeled
element (50x) or oligonucleotides containing another E-box (not the same as the probe)
for 30 min, and then incubated with the biotinylated probe. In the disruption assay,
nuclear extracts were incubated first with an antibody against DEC1 on ice for 20 min
and then with the biotinylated probe. Nuclear extracts (labeled as “n”) from cells
cultured without tetracycline were used as a control (right lane of the left panel). For
comparison, a probe derived from DEC2, known to interact with DEC1, was included.
The protein-DNA complexes were electrophoretically resolved, transferred to a
Biodyne® nylon membrane and located with streptavidin-conjugated horseradish
peroxidase and chemiluminescent substrate. (C) ChIP analysis HepG2 cells were
transfected with DEC1 (Flag-tagged) for 24 h, washed and underwent cross-linking for
15 min by 1% formaldehyde, and the cross-linking was terminated with 125 mM glycine.
Alternatively DEC1 stably transfected cells were cultured in the presence of tetracycline
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(0.1 µg/ml) for 24 h and then processed as described for HepG2 cells. The soluble
chromatins were prepared, pre-cleared with protein G beads and incubated with an
Flag antibody (HepG2) or anti-DEC1 (stably transfected cells).

As a control, the

antibody was replaced with pre-immune IgG. The antibody-bound chromatins, DNA
input (1/20 of the antibody-bound chromatins) as well as IgG-control were analyzed by
PCR for the presence of the genomic fragment containing the E-box of interest, other
E-boxes or no E-box. Both cells produced similar images and the image from HepG2
cells is shown).

Fig. 3. Inverse expression between DEC1 and SHP (A) Suppressed expression of
SHP by DEC1 HepG2 cells were seeded in 8-well chamber slides (2x104 cells/
well) and cultured for 24 h. Cells were then transfected with Flag-DEC1 (500 ng)
or the vector by TransfeX reagent.

The transfected cells were cultured for

another 24 h and subsequently fixed with 4% paraformaldehyde for 10 min at pH
7.4. Cells were permeabilized with 0.1% Triton X-100 for 10 min. Chamber slides
were incubated with 1% BSA (2mg/mL) for 1 h then incubated overnight with antiSHP antibody or anti-Flag antibody. The anti-SHP antibody was located by Alexa
Fluor® 488 conjugated goat anti-rabbit IgG (green), whereas the anti-Flag
antibody with Alexa Fluor® 555 conjugated goat anti-mouse IgG (red). The slides
were then mounted with ProLong Gold Antifade Mountant with DAPI (Blue). Cells
were then imaged with confocal microscope.

To provide more quantitative

information, same experiments were performed in 6-well plates and cell lysates
were prepared.

Lysates (10 µg) were analyzed by Western blotting for the

expression of SHP and DEC1 (Right panel). (B) Regulated expression of DEC1
and SHP by valproate in serum-shocked circadian induction HepG2 cells were
seeded in 6- or 24-well plates at a density of 6x105 or 1.5x105 cells/well and
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cultured to reach 75% confluency.

Cells were then shocked with media

containing 50% horse serum for 2 h. Thereafter, the shocked cells were cultured
in normal media or the same media containing valproate at 2 mM. Cells were
harvested at a 6 h interval. The expression of DEC1 and SHP was determined by
RT-qPCR with Taqman probes.
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